title: Surgical treatment of prolactinomas: cons.
abstract: Prolactinomas account for approximately 40 % of all pituitary adenomas. Over 95 % of prolactinomas are microadenomas (< 10 mm diameter). Treatment is indicated to correct hypogonadism, restore other hormonal deficits, and alleviate local mass effects. Dopamine agonists (DA) are highly effective in achieving these goals and are well-tolerated. The vast majority of prolactinomas will respond to conventional doses of cabergoline (≤2 mg/week) that do not carry an increased risk of cardiac valvular abnormalities. DA therapy may be successful withdrawn in a subset of patients and thus is not necessarily a lifelong commitment. Although transsphenoidal surgery (TSS) is an option for prolactinoma treatment, it is less effective than medical management, carries considerably more risk, and is more expensive. The benefit/risk ratio for DA therapy compared to TSS actually becomes increasingly more favorable as tumor size increases. Therefore DA should remain the clear treatment of choice for essentially all patients with prolactinomas, reserving TSS as a second-line option for the very small number of patients that do not tolerate or are completely resistant to DA therapy.
authors.affiliation: Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, 645 N. Michigan Ave., Suite 530, Chicago, IL, 60611, USA.
authors.forename: Eve
authors.initials: E
authors.lastname: Bloomgarden
authors.forename: Mark E
authors.initials: ME
authors.lastname: Molitch
mesh_terms: D018491:Dopamine Agonists / Q000627:therapeutic use; D006801:Humans; D019635:Neurosurgical Procedures / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000601:surgery*; D015175:Prolactinoma / Q000188:drug therapy / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D018491:Dopamine Agonists
references.citation: Neurosurg Focus. 2007;23(3):E7
references.pmid: 17961019
references.citation: Presse Med. 1995 Apr 29;24(16):753-7
references.pmid: 7784413
references.citation: J Clin Endocrinol Metab. 2012 Apr;97(4):1073-81
references.pmid: 22337908
references.citation: J Neurooncol. 2014 May;117(3):421-8
references.pmid: 24146188
references.citation: Pituitary. 2005;8(1):3-6
references.pmid: 16411062
references.citation: N Engl J Med. 1994 Oct 6;331(14):904-9
references.pmid: 7915824
references.citation: J Clin Endocrinol Metab. 2008 Dec;93(12):4721-7
references.pmid: 18812485
references.citation: Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):543-54
references.pmid: 19945022
references.citation: Eur J Endocrinol. 2009 May;160(5):747-52
references.pmid: 19223454
references.citation: J Clin Endocrinol Metab. 2010 Jan;95(1):43-51
references.pmid: 19880787
references.citation: Br J Obstet Gynaecol. 1976 Sep;83(9):683-7
references.pmid: 974045
references.citation: J Clin Endocrinol Metab. 2010 Mar;95(3):1025-33
references.pmid: 20130078
references.citation: Clin Endocrinol (Oxf). 2010 Mar;72(3):377-82
references.pmid: 19650784
references.citation: Am J Obstet Gynecol. 1972 May 1;113(1):14-20
references.pmid: 5024994
references.citation: Pituitary. 2005;8(1):53-60
references.pmid: 16411069
references.citation: Endocrinol Metab Clin North Am. 1999 Mar;28(1):119-31
references.pmid: 10207687
references.citation: Endocrine. 2015 Feb;48(1):79-82
references.pmid: 24888765
references.citation: J Clin Endocrinol Metab. 2009 Jul;94(7):2428-36
references.pmid: 19336508
references.citation: Neurosurgery. 1983 Dec;13(6):634-41
references.pmid: 6361599
references.citation: J Neurosurg. 2014 Jul;121(1):84-90
references.pmid: 24724857
references.citation: Br J Neurosurg. 2004 Oct;18(5):507-12
references.pmid: 15799155
references.citation: J Neurosurg. 2012 Sep;117(3):522-38
references.pmid: 22725987
references.citation: Cardiovasc Ther. 2011 Dec;29(6):404-10
references.pmid: 20553285
references.citation: J Clin Endocrinol Metab. 2003 Oct;88(10):4709-19
references.pmid: 14557445
references.citation: Mov Disord. 2007 Oct 15;22(13):1936-42
references.pmid: 17659636
references.citation: J Clin Endocrinol Metab. 1997 Mar;82(3):876-83
references.pmid: 9062500
references.citation: Am J Surg. 2005 Sep;190(3):467-73
references.pmid: 16105538
references.citation: Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):885-96
references.pmid: 22115164
references.citation: Eur J Endocrinol. 2012 May;166(5):779-86
references.pmid: 22301915